Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy

Philip A. Barber, Andrew M. Demchuk, Jinjin Zhang et al. · The Lancet · 2000 · 2.6K citations

Medicine, Clinical Sciences, Neurology +16

Why are stroke patients excluded from TPA therapy?

P A Barber, Joyce L. Zhang, Andrew M. Demchuk et al. · Neurology · 2001 · 708 citations

Medicine, Emergency Medicine, Neurology +14

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

Bijoy K. Menon, Brian Buck, Nishita Singh et al. · The Lancet · 2022 · 450 citations

Medicine, Neurology, Pharmacotherapy +11

Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits

Pooja Khatri, Dawn Kleindorfer, Thomas Devlin et al. · JAMA · 2018 · 399 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Simplified Modified Rankin Scale Questionnaire

Askiel Bruno, Abiodun Akinwuntan, Chen Lin et al. · Stroke · 2011 · 357 citations · Full text

Medicine, Neurology, Health Assessment +15